ZAGREB ZAGREB, Nov 5 (Hina) - The Pliva pharmaceutical company has received an approval of the US Food and Drug Administration (FDA) for production plants in Zagreb, including a new plant for the production of oral medications, Zagreb
Stock Exchange officials reported on Tuesday.
ZAGREB, Nov 5 (Hina) - The Pliva pharmaceutical company has
received an approval of the US Food and Drug Administration (FDA)
for production plants in Zagreb, including a new plant for the
production of oral medications, Zagreb Stock Exchange officials
reported on Tuesday. #L#
This is another step which enables this leading Croatian
pharmaceutical company to register its products in the United
States and Great Britain. The FDA decision will help the company
receive approval of other west European countries, Pliva officials
said.
Between August 26 and 30, the FDA completed a Pre-Approval
Inspection (PAI) and the inspection of Good Manufacturing Practice
(GMP).
This approval was granted after the inspection and approval of the
British Medicine Control Agency (MCA) for dry, oral forms of
medications and sterile injection in manufacturing plants in
Zagreb in July 2002.
(hina) it sb